Differences in carotid plaque content of macrophages, T cells and MMP-9 between patients with embolic and hemodynamic cerebral ischemia due to symptomatic carotid stenosis

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 456-460

  Kunte, Hagen ^a   Kunte, Gerolf ^a   Busch, Markus Alexander ^b   Weichert, Wilko ^a   Rückert, Ralph Ingo ^c   Harms, Lutz ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

Atherosclerosis risk factors; Carotid stenosis; Plaque analysis

Indexed keywords

GELATINASE B;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PLAQUE FORMING CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; BRAIN ISCHEMIA; CAROTID STENOSIS; FEMALE; HEMODYNAMICS; HUMANS; INFLAMMATION; INTRACRANIAL EMBOLISM; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; T-LYMPHOCYTES;

EID: 77955239247     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.005     Document Type: Article

References (24)

1. Golledge J., Siew D.A. Identifying the carotid 'high risk' plaque: is it still a riddle wrapped up in an enigma?. Eur J Vasc Endovasc Surg 2008, 35:2-8.
2. Barnett H.J., Taylor D.W., Eliasziw M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998, 339:1415-1425.
3. Rothwell P.M., Eliasziw M., Gutnikov S.A., Warlow C.P., Barnett H.J. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004, 363:915-924.
4. Fairhead J.F., Mehta Z., Rothwell P.M. Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology 2005, 65:371-375.
5. Carotid surgery vs. medical therapy in asymptomatic carotid stenosis. Stroke 1991, 22:1229-1235. The CASANOVA Study Group.
6. Hobson R.W., Weiss D.G., Fields W.S., et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993, 328:221-227.
7. Carr S.C., Farb A., Pearce W.H., Virmani R., Yao J.S. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery 1997, 122:757-763. discussion 763-754.
8. Golledge J., Greenhalgh R.M., Davies A.H. The symptomatic carotid plaque. Stroke 2000, 31:774-781.
9. Jander S., Sitzer M., Schumann R., et al. Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 1998, 29:1625-1630.
10. Loftus I.M., Naylor A.R., Goodall S., et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 2000, 31:40-47.
11. Stoll G., Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006, 37:1923-1932.
12. Badimon J.J., Ibanez B., Cimmino G. Genesis and dynamics of atherosclerotic lesions: implications for early detection. Cerebrovasc Dis 2009, 27(Suppl 1):38-47.
13. Mead G.E., O'Neill P.A. Carotid disease in acute stroke: a review. J Stroke Cerebrovasc Dis 1999, 8:197-206.
14. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991, 325:445-453.
15. Rothwell P.M., Eliasziw M., Gutnikov S.A., Warlow C.P., Barnett H.J. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004, 363:915-924.
16. Ringleb P.A., Allenberg J., Bruckmann H., et al. 30 day results from the SPACE trial of stent-protected angioplasty vs. carotid endarterectomy in symptomatic patients: a randomized non-inferiority trial. Lancet 2006, 368:1239-1247.
17. Redgrave J.N., Lovett J.K., Gallagher P.J., Rothwell P.M. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006, 113:2320-2328.
18. Kunte H., Amberger N., Busch M.A., et al. Markers of instability in high-risk carotid plaques are reduced by statins. J Vasc Surg 2008, 47:513-522.
19. Derdeyn C.P., Carpenter D.A., Videen T.O., Grubb R.L., Powers W.J. Patterns of infarction in hemodynamic failure. Cerebrovasc Dis 2007, 24:11-19.
20. Momjian-Mayor I., Baron J.C. The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies. Stroke 2005, 36:567-577.
21. Crawley F., Clifton A., Buckenham T., et al. Comparison of hemodynamic cerebral ischemia and microembolic signals detected during carotid endarterectomy and carotid angioplasty. Stroke 1997, 28:2460-2464.
22. Reimers B., Corvaja N., Moshiri S., et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 2001, 104:12-15.
23. Rosenkranz M., Wittkugel O., Waiblinger C., et al. Cerebral embolism during carotid artery stenting: role of carotid plaque echolucency. Cerebrovasc Dis 2009, 27:443-449.
24. Jansen O., Fiehler J., Hartmann M., Bruckmann H. Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial. Stroke 2009, 40:841-846.